Subscribe To
Precede Biosciences Unveils Groundbreaking Clinical Data for its Pioneering Liquid Biopsy Platform at ESMO 2023 and Simultaneously Publishes in Nature Medicine
Pivotal findings stem from Precede’s first-in-class platform in collaboration with Dana-Farber Cancer Institute Results underscore the immense potential of the blood-based platform to impact therapeutic and clinical decision-making Published dataset is largest of its kind, with over 1,200 cell-free-DNA transcriptional profiles from more than 400 patients affected with 15 different cancers BOSTON, Oct. 21, 2023 […] The post Precede Biosciences Unveils Groundbreaking Clinical Data for its Pioneeri...
Read More
Posted: Oct 21 2023, 08:25
Author Name: forextv
Views: 092090